vs
INSEEGO CORP.（INSG）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
INSEEGO CORP.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$48.4M vs $35.5M），INSEEGO CORP.净利率更高（1.0% vs -304.2%，领先305.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 0.6%），INSEEGO CORP.自由现金流更多（$11.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 13.6%）
Inseego Corp是全球领先的5G及物联网解决方案提供商，主打移动热点、边缘计算设备及云端设备管理平台产品，客户覆盖全球范围内的电信运营商、企业及公共部门。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
INSG vs RXRX — 直观对比
营收规模更大
INSG
是对方的1.4倍
$35.5M
营收增速更快
RXRX
高出681.1%
0.6%
净利率更高
INSG
高出305.2%
-304.2%
自由现金流更多
INSG
多$58.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.4M | $35.5M |
| 净利润 | $469.0K | $-108.1M |
| 毛利率 | 42.2% | 59.8% |
| 营业利润率 | 2.7% | -304.8% |
| 净利率 | 1.0% | -304.2% |
| 营收同比 | 0.6% | 681.7% |
| 净利润同比 | 182.9% | 39.6% |
| 每股收益（稀释后） | $-0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSGRXRX
| Q4 25 | $48.4M | $35.5M | ||
| Q3 25 | $45.9M | $5.2M | ||
| Q2 25 | $40.2M | $19.2M | ||
| Q1 25 | $31.7M | $14.7M | ||
| Q4 24 | $48.1M | $4.5M | ||
| Q3 24 | $54.0M | $26.1M | ||
| Q2 24 | $51.6M | $14.4M | ||
| Q1 24 | $37.5M | $13.8M |
净利润INSGRXRX
| Q4 25 | $469.0K | $-108.1M | ||
| Q3 25 | $1.4M | $-162.3M | ||
| Q2 25 | $507.0K | $-171.9M | ||
| Q1 25 | $-1.6M | $-202.5M | ||
| Q4 24 | $-566.0K | $-178.9M | ||
| Q3 24 | $9.0M | $-95.8M | ||
| Q2 24 | $624.0K | $-97.5M | ||
| Q1 24 | $-4.5M | $-91.4M |
毛利率INSGRXRX
| Q4 25 | 42.2% | 59.8% | ||
| Q3 25 | 41.6% | -183.8% | ||
| Q2 25 | 41.1% | -4.9% | ||
| Q1 25 | 47.3% | -48.0% | ||
| Q4 24 | 37.3% | -181.4% | ||
| Q3 24 | 34.8% | 53.7% | ||
| Q2 24 | 36.4% | 36.2% | ||
| Q1 24 | 35.3% | 19.1% |
营业利润率INSGRXRX
| Q4 25 | 2.7% | -304.8% | ||
| Q3 25 | 4.7% | -3327.6% | ||
| Q2 25 | 3.2% | -916.8% | ||
| Q1 25 | -1.3% | -1297.9% | ||
| Q4 24 | 3.7% | -4042.4% | ||
| Q3 24 | 1.9% | -377.1% | ||
| Q2 24 | 3.6% | -697.4% | ||
| Q1 24 | -7.9% | -698.4% |
净利率INSGRXRX
| Q4 25 | 1.0% | -304.2% | ||
| Q3 25 | 3.1% | -3135.3% | ||
| Q2 25 | 1.3% | -894.2% | ||
| Q1 25 | -5.0% | -1373.3% | ||
| Q4 24 | -1.2% | -3935.5% | ||
| Q3 24 | 16.6% | -367.5% | ||
| Q2 24 | 1.2% | -676.6% | ||
| Q1 24 | -11.9% | -662.4% |
每股收益（稀释后）INSGRXRX
| Q4 25 | $-0.02 | $-0.17 | ||
| Q3 25 | $0.03 | $-0.36 | ||
| Q2 25 | $-0.03 | $-0.41 | ||
| Q1 25 | $-0.16 | $-0.50 | ||
| Q4 24 | $0.62 | $-0.56 | ||
| Q3 24 | $-0.06 | $-0.34 | ||
| Q2 24 | $-0.02 | $-0.40 | ||
| Q1 24 | $-0.44 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-4.0M | $1.1B |
| 总资产 | $93.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资INSGRXRX
| Q4 25 | $24.9M | $743.3M | ||
| Q3 25 | $14.6M | $659.8M | ||
| Q2 25 | $13.2M | $525.1M | ||
| Q1 25 | $35.1M | $500.5M | ||
| Q4 24 | $39.6M | $594.4M | ||
| Q3 24 | $12.0M | $427.6M | ||
| Q2 24 | $49.0M | $474.3M | ||
| Q1 24 | $12.3M | $296.3M |
总债务INSGRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益INSGRXRX
| Q4 25 | $-4.0M | $1.1B | ||
| Q3 25 | $-7.7M | $1.0B | ||
| Q2 25 | $-10.5M | $919.1M | ||
| Q1 25 | $-13.0M | $933.9M | ||
| Q4 24 | $-12.9M | $1.0B | ||
| Q3 24 | $-85.1M | $524.6M | ||
| Q2 24 | $-101.8M | $584.4M | ||
| Q1 24 | $-105.6M | $401.2M |
总资产INSGRXRX
| Q4 25 | $93.8M | $1.5B | ||
| Q3 25 | $85.8M | $1.4B | ||
| Q2 25 | $83.1M | $1.3B | ||
| Q1 25 | $93.0M | $1.3B | ||
| Q4 24 | $100.0M | $1.4B | ||
| Q3 24 | $113.4M | $726.5M | ||
| Q2 24 | $149.6M | $775.9M | ||
| Q1 24 | $122.1M | $557.8M |
负债/权益比INSGRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 24.0% | -133.1% |
| 资本支出强度资本支出/营收 | 0.7% | 3.5% |
| 现金转化率经营现金流/净利润 | 25.50× | — |
| 过去12个月自由现金流最近4个季度 | $6.5M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流INSGRXRX
| Q4 25 | $12.0M | $-46.1M | ||
| Q3 25 | $3.2M | $-117.4M | ||
| Q2 25 | $-4.5M | $-76.4M | ||
| Q1 25 | $-3.5M | $-132.0M | ||
| Q4 24 | $-14.2M | $-115.4M | ||
| Q3 24 | $14.8M | $-59.2M | ||
| Q2 24 | $27.6M | $-82.2M | ||
| Q1 24 | $5.2M | $-102.3M |
自由现金流INSGRXRX
| Q4 25 | $11.6M | $-47.3M | ||
| Q3 25 | $3.1M | $-117.6M | ||
| Q2 25 | $-4.7M | $-79.6M | ||
| Q1 25 | $-3.5M | $-133.8M | ||
| Q4 24 | $-14.3M | $-116.7M | ||
| Q3 24 | $14.8M | $-63.8M | ||
| Q2 24 | $27.6M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率INSGRXRX
| Q4 25 | 24.0% | -133.1% | ||
| Q3 25 | 6.7% | -2272.5% | ||
| Q2 25 | -11.6% | -413.9% | ||
| Q1 25 | -11.0% | -907.4% | ||
| Q4 24 | -29.7% | -2567.7% | ||
| Q3 24 | 27.4% | -244.6% | ||
| Q2 24 | 53.5% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度INSGRXRX
| Q4 25 | 0.7% | 3.5% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
现金转化率INSGRXRX
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | — | ||
| Q2 25 | -8.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
